本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ascendis Pharma A/S

247.69
+7.923.30%
盤後247.690.00000.00%19:57 EDT
成交量:126.01萬
成交額:3.09億
市值:163.95億
市盈率:19.11
高:249.01
開:239.70
低:237.23
收:239.77
52周最高:282.15
52周最低:186.05
股本:6,618.99萬
流通股本:6,553.95萬
量比:1.31
換手率:1.92%
股息:- -
股息率:- -
每股收益(TTM):12.96
每股收益(LYR):-4.4176
淨資產收益率:118.78%
總資產收益率:9.58%
市淨率:9.95
市盈率(LYR):-56.07

資料載入中...

2019/11/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/23

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/05/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]